Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Publications

Correction: Large simple randomized controlled trials-from drugs to medical devices: lessons from recent experience.

Buccheri S. et al, (2025), Trials, 26

Sotrovimab versus usual care in patients admitted to hospital with COVID-19: a randomised, controlled, open-label, platform trial (RECOVERY)

Horby PW. et al, (2025)

Large simple randomized controlled trials-from drugs to medical devices: lessons from recent experience.

Buccheri S. et al, (2025), Trials, 26

The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial.

Judge PK. et al, (2024), Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Retraction Note: Development and evaluation of rapid data-enabled access to routine clinical information to enhance early recruitment to the national clinical platform trial of COVID-19 community treatments.

Cake C. et al, (2024), Trials, 25

Time of day for vaccination, outcomes, and relative effectiveness of high-dose vs. standard-dose quadrivalent influenza vaccine: a post-hoc analysis of the DANFLU-1 randomized clinical trial

LANDRAY M., (2024), Journal of Infection

Accelerating Evidence Generation: Addressing Critical Challenges and Charting a Path Forward

LANDRAY M., (2024), Journal of Clinical and Translational Science

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

Horby PW. et al, (2024)

Overcoming the barriers to better evidence generation from clinical trials

LANDRAY M., (2024), Trials

In Practice: RECOVERY Trial

HORBY P. et al, (2024), Principles and Practice of Emergency Research Response

Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial

Mayne K. et al, (2024), Nephrology Dialysis Transplantation

High-Dose vs Standard-Dose Influenza Vaccine in Chronic Kidney Disease: A Secondary Analysis of DANFLU-1.

Bartholdy KV. et al, (2024), Journal of the American College of Cardiology

Relative Effectiveness of High-Dose vs. Standard-Dose Quadrivalent Influenza Vaccine in Older Adults with Cardiovascular Disease: A Prespecified Analysis of the DANFLU-1 Randomized Clinical Trial.

Christensen J. et al, (2024), Circulation. Cardiovascular quality and outcomes

Sodium-glucose co-transporter 2 inhibitors (SGLT2i) for hospitalised patients with COVID-19: prospective meta-analysis of randomised trials

LANDRAY M. et al, (2024), The Lancet Diabetes and Endocrinology

Frailty, multimorbidity and polypharmacy: exploratory analyses of the effects of empagliflozin from the EMPA-KIDNEY trial.

Mayne KJ. et al, (2024), Clin J Am Soc Nephrol

Clinical trial results in context: comparison of baseline characteristics and outcomes of 38,510 RECOVERY trial participants versus a reference population of 346,271 people hospitalised with COVID-19 in England.

Pessoa-Amorim G. et al, (2024), Trials, 25

The Integration of Clinical Trials With the Practice of Medicine: Repairing a House Divided.

Angus DC. et al, (2024), JAMA

Effects of high-dose versus standard-dose quadrivalent influenza vaccine among patients with diabetes: A post-hoc analysis of the DANFLU-1 trial.

Lassen MCH. et al, (2024), Diabetes, obesity & metabolism, 26, 1821 - 1829

Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis.

Cholesterol Treatment Trialists’ (CTT) Collaboration. Electronic address: ctt@ndph.ox.ac.uk None. and Cholesterol Treatment Trialists’ (CTT) Collaboration None., (2024), The lancet. Diabetes & endocrinology, 12, 306 - 319

Framework of the Strengths and Challenges of Clinically Integrated Trials: An Expert Panel Report

Peters AE. et al, (2024), American Heart Journal

Load More